Fiera Capital Corp Eli Lilly & CO Transaction History

Fiera Capital Corp

$31.6 Billion
Q3 2024

A detailed history of Fiera Capital Corp transactions in Eli Lilly & CO stock. As of the latest transaction made, Fiera Capital Corp holds 23,172 shares of LLY stock, worth $17.3 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

23,172

Previous 22,648 2.31%

Holding current value

$17.3 Million

Previous $20.5 Million 0.12%

% of portfolio

0.06%

Previous 0.07%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 01, 2024	BUY	$772.14 - $960.02 $404,601 - $503,050	524 Added 2.31%	23,172 $20.5 Million
Q2 2024 Aug 01, 2024	BUY	$724.87 - $909.04 $4.28 Million - $5.37 Million	5,908 Added 35.29%	22,648 $20.5 Million
Q1 2024 Aug 22, 2024	SELL	$592.2 - $792.28 $3.5 Million - $4.68 Million	-5,908 Reduced 26.09%	16,740 $13 Million
Q1 2024 May 01, 2024	BUY	$592.2 - $792.28 $2.03 Million - $2.71 Million	3,424 Added 25.71%	16,740 $13 Million
Q4 2023 Aug 22, 2024	SELL	$525.19 - $619.13 $858,685 - $1.01 Million	-1,635 Reduced 10.94%	13,316 $7.76 Million
Q4 2023 Feb 08, 2024	SELL	$525.19 - $619.13 $858,685 - $1.01 Million	-1,635 Reduced 10.94%	13,316 $7.76 Million
Q3 2023 Aug 22, 2024	SELL	$434.7 - $599.3 $3.35 Million - $4.61 Million	-7,697 Reduced 33.99%	14,951 $8.03 Million
Q3 2023 Nov 09, 2023	SELL	$434.7 - $599.3 $843,318 - $1.16 Million	-1,940 Reduced 11.49%	14,951 $8.03 Million
Q2 2023 Aug 09, 2023	SELL	$350.74 - $468.98 $1.13 Million - $1.51 Million	-3,218 Reduced 16.0%	16,891 $7.92 Million
Q1 2023 Apr 26, 2023	BUY	$310.63 - $364.82 $608,213 - $714,317	1,958 Added 10.79%	20,109 $6.91 Million
Q4 2022 Feb 08, 2023	SELL	$321.55 - $374.67 $304,186 - $354,437	-946 Reduced 4.95%	18,151 $6.64 Million
Q3 2022 Nov 03, 2022	BUY	$296.48 - $337.87 $528,030 - $601,746	1,781 Added 10.29%	19,097 $5.9 Million
Q2 2022 Aug 10, 2022	BUY	$278.73 - $327.27 $320,539 - $376,360	1,150 Added 7.11%	17,316 $5.61 Million
Q1 2022 May 09, 2022	BUY	$234.69 - $291.66 $90,355 - $112,289	385 Added 2.44%	16,166 $4.63 Million
Q4 2021 Feb 08, 2022	BUY	$224.85 - $279.04 $8,319 - $10,324	37 Added 0.24%	15,781 $4.36 Million
Q3 2021 Nov 12, 2021	SELL	$221.6 - $272.71 $677,431 - $833,674	-3,057 Reduced 16.26%	15,744 $3.64 Million
Q2 2021 Aug 11, 2021	BUY	$180.55 - $233.54 $638,605 - $826,030	3,537 Added 23.17%	18,801 $3.09 Million
Q1 2021 May 11, 2021	SELL	$164.32 - $212.72 $201,620 - $261,007	-1,227 Reduced 7.44%	15,264 $2.85 Million
Q4 2020 Feb 09, 2021	BUY	$130.46 - $172.63 $1.52 Million - $2.02 Million	11,686 Added 243.2%	16,491 $2.78 Million
Q3 2020 Nov 12, 2020	BUY	$146.22 - $169.13 $309,840 - $358,386	2,119 Added 78.89%	4,805 $711,000
Q2 2020 Aug 07, 2020	SELL	$136.42 - $164.18 $1.66 Million - $2 Million	-12,152 Reduced 81.9%	2,686 $441,000
Q1 2020 May 08, 2020	SELL	$119.05 - $147.35 $1.41 Million - $1.74 Million	-11,842 Reduced 44.39%	14,838 $2.06 Million
Q4 2019 Feb 06, 2020	BUY	$106.92 - $132.43 $2.85 Million - $3.53 Million	26,680 New	26,680 $3.51 Million
Q2 2019 Aug 12, 2019	SELL	$110.79 - $129.32 $864,937 - $1.01 Million	-7,807 Closed	0 $0
Q1 2019 May 10, 2019	BUY	$111.31 - $131.02 $173,866 - $204,653	1,562 Added 25.01%	7,807 $1.01 Million
Q4 2018 Feb 12, 2019	SELL	$105.9 - $118.64 $169,440 - $189,824	-1,600 Reduced 20.4%	6,245 $723,000
Q3 2018 Nov 13, 2018	SELL	$85.86 - $107.31 $41,727 - $52,152	-486 Reduced 5.83%	7,845 $842,000
Q2 2018 Aug 02, 2018	SELL	$75.7 - $86.88 $51,778 - $59,425	-684 Reduced 7.59%	8,331 $711,000
Q1 2018 May 11, 2018	SELL	$74.21 - $87.6 $1.14 Million - $1.34 Million	-15,319 Reduced 62.95%	9,015 $697,000
Q4 2017 Feb 09, 2018	SELL	$81.94 - $87.89 $74,729 - $80,155	-912 Reduced 3.61%	24,334 $2.06 Million
Q3 2017 Nov 13, 2017	BUY	$77.07 - $85.54 $1.95 Million - $2.16 Million	25,246	25,246 $2.16 Million

Others Institutions Holding LLY

# of Institutions

4,004

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $711B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fiera Capital Corp, based on Form 13F filings with the SEC.

News

Stay updated on Fiera Capital Corp with notifications on news.

Account

Fiera Capital Corp Eli Lilly & CO Transaction History